Inmode Ltd Dossier
Qualitative Analysis
Business overview
InMode Ltd. (NASDAQ: INMD) is a leading global provider of innovative medical technologies that designs, develops, manufactures, and markets energy-based devices leveraging proprietary radiofrequency (RF) technology. The company's minimally invasive and non-invasive aesthetic and medical treatment solutions address key categories including face and body contouring, medical aesthetics, and women's health. Operating a high-margin "razor-and-blade" business model, InMode generates recurring revenue through consumables and service agreements alongside capital equipment sales. Headquartered in Yokne'am, Israel, the company serves plastic surgeons, dermatologists, gynecologists, and ophthalmologists globally.
Research as of 19 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Transitioned from a long-standing East-West sales structure to a unified North American model, integrating Canada and the Gulf Coast under a single management team to improve coordination and accountability.
Expected impact: Aims to stabilize North American capital equipment sales and improve sales force execution.
Separated the Envision platform sales team into an independent, dedicated ophthalmology and optometry sales force consisting of approximately 30 representatives.
Expected impact: Aims to drive deeper penetration of the Envision platform for dry eye treatments by utilizing specialized sales knowledge.
Utilizing a wholly owned subsidiary in Guangzhou to target the spa and cosmetic (non-medical) segment in China, including hiring a specialized manager and developing distinct product lines.
Expected impact: Aims to capture market share in China's massive beauty and wellness industry, diversifying away from strictly medical aesthetic clinics.